Loading your page…
Leukemia, Lymphocytic, Chronic, B-Cell;Lymphoma, Follicular
Marketing Authorisation Holder: Secura Bio Limited
EMA Authorisation: 19/05/2021
INN: duvelisib
AI Drug & Interaction Analysis
Free account required
Ask Osler about Copiktra: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.
